License Agreement and Asset Acquisition - Schedule of Asset Acquisition (Details) - Chimerix - USD ($) $ in Thousands		1 Months Ended
	Apr. 21, 2025	Apr. 30, 2025
Consideration
Total cash consideration paid to Chimerix	$ 944,200	$ 944,154
Transaction costs		13,237
Total consideration		957,391
Cash		99,338
In-process research and development		905,362
Accrued liabilities		(53,066)
Other assets and liabilities		5,757
Total net assets acquired		957,391
Outstanding Common Stock
Consideration
Total cash consideration paid to Chimerix		802,023
Outstanding Equity Awards
Consideration
Total cash consideration paid to Chimerix		$ 142,131